References
- Abrahamson, M. Olafsson, I. Palsdottir, A. et al. (1990). Structure and expression of the human cystatin C gene Biochem Journal.
- Akgül, B. Bauer, B. Zigrino, P. Storey, A. Mauch, C. Pfister, H. (2011). Upregulation of lipocalin-2 in human papillomavirus-positive keratinocytes and cutaneous squamous cell carcinomas. J. Gen. Virol.
- Bunel, V. Tournay, Y. Baudoux, T. De Prez, E. Marchand, M. Mekinda, Z. et al. (2017). Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers. Clin Kidney J.
- Coll, E. Botey, A. Alvarez, L. et al. (2000). Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis.
- Herget-Rosenthal, S. et al. (2004). Early detection of acute renal failure by serum cystatin C Kidney Int (2004) Volume 66, Issue 3, September 2004, Pages 1115-1122.
- Kawakami, M. Hirata, S. Mizuta, M. et al. (2019). Modified serum creatinine-derived equations with muscle mass-adjusted estimation of renal function and serum cystatin C-derived estimated glomerular filtration rate in elderly individuals. Int J Clin Pharmacol.
- Khwaja, A. (2012). KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract.
- Kozan, R. Şare, M. Yılmaz, T., et al. (2018). Effectiveness of new parameters in the evaluation of pneumoperitoneum-related acute kidney injury in rats. Turk J Med Sci.
- Lin, H. Lee, S. Lin, S Hsiao, H. Liu, Y. Yang, W. et al. (2013). Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels. Kaohsiung J Med Sci.
- Ma, G. Cheng, W. Ma, M. (2019). Effect of Docetaxel Combined with Cisplatin Preoperative Neoadjuvant Chemotherapy for Stage III NSCLC. J Coll Physicians Surg Pak.
- Maghsoudi O, Mirjalili Sh, Dolatabadi M, Joshaghani Mf, Zarea M, Yahaghi E, Mokarizadeh A. (2015). Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy. Diagn Pathol.
- Mishra, J. Mori, K. Ma, Q. Kelly, C. Barasch, J. Devarajan, P. (2004). Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol.
- Mussap, M. Dalla, M. Fioretto, P. et al. (2002). Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. pp.
- Ostermann, M. Zarbock, A. Goldstein, S. Kashani, K. Macedo, E. Murugan, R. Bell, M. Forni, L. Guzzi, L. Joannidis, M. (2020). Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: A consensus statement. JAMA Netw. Open.
- Peres, L., Cunha Júnior, A. Assumpção, R. Schäfer, A. Silva, A. Gaspar, A. et al. (2014). Evaluation of the cisplatin nephrotoxicity using the urinary neutrophil gelatinase-associated lipocalin (NGAL) in patients with head and neck cancer. Jornal Brasileiro Nefrologia.
- Pokrivčák, T. Poprach, A. (2017). Cancer Treatment-induced Changes in Renal Function in Patients with Tumors - Update on Current Knowledge. Klin Onkol.
- Romejko, K. Markowska, M. Niemczyk, S. (2023). The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int J Mol Sci.
- Scarr, D. Bjornstad, P. Lovblom, L. E. et al. (2019). Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes. Kidney Int Rep.
- Wang, Y. Chen, J. Y. Yue-Ming, J. et al. (2007). Postharvest Biology and Technology. Volume 44, Issue 1.